Inventiva
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inventiva and buy or sell other stocks, ETFs, and their options commission-free!About IVA
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors.
CEOAndrew Obenshain
CEOAndrew Obenshain
Employees119
Employees119
HeadquartersDaix, Bourgogne-Franche-Comte
HeadquartersDaix, Bourgogne-Franche-Comte
Founded2011
Founded2011
Employees119
Employees119
IVA Key Statistics
Market cap836.55M
Market cap836.55M
Price-Earnings ratio-1.07
Price-Earnings ratio-1.07
Dividend yield—
Dividend yield—
Average volume278.45K
Average volume278.45K
High today$4.62
High today$4.62
Low today$4.62
Low today$4.62
Open price$4.63
Open price$4.63
Volume6.86K
Volume6.86K
52 Week high$7.98
52 Week high$7.98
52 Week low$2.11
52 Week low$2.11
Stock Snapshot
The current Inventiva(IVA) stock price is $4.62, with a market capitalization of 836.55M. The stock trades at a price-to-earnings (P/E) ratio of -1.07.
During the trading session on 2025-12-18, Inventiva(IVA) shares reached a daily high of $4.62 and a low of $4.62. At a current price of $4.62, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 6.86K, compared to an average daily volume of 278.45K.
The stock's 52-week range extends from a low of $2.11 to a high of $7.98.
The stock's 52-week range extends from a low of $2.11 to a high of $7.98.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%